US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

iHuman

2.17

+0.09404.52%

Post-market: 2.170.00000.00%16:39 EDT

Volume:10.40K

Turnover:21.90K

Market Cap:113.08M

PE:8.82

High:2.18

Open:2.01

Low:2.00

Close:2.08

Loading ...

Overview Company News Filings

JAZZ vs. HRMY: Which Neuroscience Drugmaker Is the Stronger Play?

Avadel and nference Announce Publication of Real-World Data on Sodium Oxybate Treatment Patterns in the Journal of Clinical Neuroscience

Is Jazz Pharmaceuticals a Top Cannabis Investment for 2025?

Avadel Pharmaceuticals Provides Update at Needham Virtual Healthcare Conference

Harmony Biosciences Holdings, Inc. (HRMY): A Bull Case Theory

Incannex Healthcare Completes Phase 2 Enrollment in RePOSA Phase 2/3 Trial of IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)

Do Its Financials Have Any Role To Play In Driving iHuman Inc.'s (NYSE:IH) Stock Up Recently?

Simply Wall St.

Stock Track | iHuman Stock Plummets 5.79% Following Disappointing Q4 and Full Year 2024 Results

Stock Track | iHuman Stock Plummets 5.79% as Q4 Revenue and Profit Decline

Ihuman Inc. Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results

THOMSON REUTERS

Ihuman Q4 Gross Profit RMB 156.4 Million

THOMSON REUTERS

Press Release: iHuman Inc. Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results

CNH Industrial says precision technology helping farmers tackle water scarcity

Press Release: Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2024

HRMY Down 10.8% in Six Months: How Should You Play the Stock?

Zevra Reports Full Year 2024 and Fourth Quarter Financial Results

BUZZ-U.S. STOCKS ON THE MOVE-Willis Lease Finance, CME Group

Centessa Pharmaceuticals Announces Poster Presentation of Phase 1 Clinical Data for ORX750, a novel orexin receptor 2 (OX2R) agonist, at the American Academy of Neurology (AAN) 2025 Annual Meeting

Stock Track | iHuman Stock Soars 6.54% as Lumryz Sales Surge and 2025 Guidance Reaffirmed

Avadel Pharmaceuticals Reiterates 2025 Guidance as it Reports Fourth Quarter and Full Year 2024 Financial Results

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/IH/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IH\",,,,,undefined,":{"symbol":"IH","market":"US","secType":"STK","nameCN":"iHuman","latestPrice":2.174,"timestamp":1745611200000,"preClose":2.08,"halted":0,"volume":10395,"hourTrading":{"tag":"盘后","latestPrice":2.174,"preClose":2.174,"latestTime":"16:39 EDT","volume":9,"amount":19.608,"timestamp":1745613571180},"delay":0,"floatShares":15216840,"shares":52016841,"eps":0.246606,"marketStatus":"Market Closed","change":0.094,"latestTime":"04-25 16:00:00 EDT","open":2.01,"high":2.18,"low":2,"amount":21897.834651,"amplitude":0.086538,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.246606,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745827200000},"marketStatusCode":7,"adr":0,"adrRate":5,"listingDate":1602216000000,"exchange":"NYSE","adjPreClose":2.08,"postHourTrading":{"tag":"盘后","latestPrice":2.174,"preClose":2.174,"latestTime":"16:39 EDT","volume":9,"amount":19.608,"timestamp":1745613571180},"volumeRatio":0.8536585344822407},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IH\",,,,,undefined,":{"symbol":"IH","floatShares":15216840,"roa":"3.13%","roe":"10.28%","lyrEps":0.257765,"volumeRatio":0.8536585344822407,"shares":52016841,"dividePrice":0,"high":2.18,"amplitude":0.086538,"preClose":2.08,"low":2,"week52Low":1.47,"pbRate":"0.86","psRate":"0.89","week52High":3.18,"institutionHeld":0,"latestPrice":2.174,"eps":0.246606,"divideRate":0,"volume":10395,"delay":0,"ttmEps":0.246606,"open":2.01,"prevYearClose":1.69,"prevWeekClose":1.96,"prevMonthClose":2.12,"prevQuarterClose":2.12,"fiveDayClose":1.96,"twentyDayClose":2.39,"sixtyDayClose":1.66},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IH\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529801776","title":"JAZZ vs. HRMY: Which Neuroscience Drugmaker Is the Stronger Play?","url":"https://stock-news.laohu8.com/highlight/detail?id=2529801776","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529801776?lang=en_us&edition=fundamental","pubTime":"2025-04-21 19:36","pubTimestamp":1745235360,"startTime":"0","endTime":"0","summary":"Jazz Pharmaceuticals JAZZ and Harmony Biosciences HRMY have emerged as notable players in the neuroscience space, especially in the sleep disorder segment.Jazz Pharmaceuticals markets multiple neuroscience drugs, including the blockbuster oral sleep disorder drug Xywav and the cannabidiol  drug Epidiolex.Harmony Biosciences has only one marketed drug in its portfolio, Wakix , which is approved to treat excessive daytime sleepiness  or cataplexy in narcolepsy patients.Both companies are experiencing consistent sales and earnings growth. But, which one makes for a better investment pick today?Total 2024 revenues rose 6% year over year to $4.1 billion, which includes $2.9 billion from the neuroscience franchise and","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/jazz-vs-hrmy-neuroscience-drugmaker-113600835.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0320765992.SGD","JAZZ","LU0823416689.USD","FXS","BK4113","IH","BK4533","HRMY","BK4563","CBD","IE00BN0W2W23.USD","BK4532","BK4085","IE00BN0W2V16.EUR","LU0889565916.HKD","LU0109394709.USD","IE00BN0W2T93.GBP","BK4510","BK4007"],"gpt_icon":0},{"id":"2528711886","title":"Avadel and nference Announce Publication of Real-World Data on Sodium Oxybate Treatment Patterns in the Journal of Clinical Neuroscience","url":"https://stock-news.laohu8.com/highlight/detail?id=2528711886","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528711886?lang=en_us&edition=fundamental","pubTime":"2025-04-17 20:00","pubTimestamp":1744891200,"startTime":"0","endTime":"0","summary":"-- Retrospective analysis reveals no significant differences in comorbidities in narcolepsy patients treated vs. not treated with sodium oxybate --. -- One third of patients taking immediate-release, twice-nightly sodium oxybate discontinued treatment, most often due to lack of efficacy; inability to wake up was most common reason for missing second nightly dose --. DUBLIN, April 17, 2025  -- Avadel Pharmaceuticals plc, a biopharmaceutical company focused on transforming medicines to transform lives, andnference, a health tech company dedicated to making biomedical data computable, today announced the publication of real-world data on comorbidities and treatment patterns of people with narcolepsy treated versus not treated with immediate-release sodium oxybate. The paper, titled “Characterization and Treatment Patterns of Patients Treated With Immediate-Release Sodium Oxybate for Narcolepsy: A Propensity-Matched Cohort Study,” was published online in the Journal of Clinical Neuroscienc","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/avadel-nference-announce-publication-real-120000945.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4510","BK4563","BK4085","AVDL","BK4007","IH"],"gpt_icon":0},{"id":"2528771768","title":"Is Jazz Pharmaceuticals a Top Cannabis Investment for 2025?","url":"https://stock-news.laohu8.com/highlight/detail?id=2528771768","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528771768?lang=en_us&edition=fundamental","pubTime":"2025-04-17 19:49","pubTimestamp":1744890540,"startTime":"0","endTime":"0","summary":"While JAZZ Pharmaceuticals JAZZ may not be a typical cannabis stock, it is the only company to market an FDA-approved drug that contains a purified drug substance derived from marijuana.The company entered the medical cannabis space after acquiring GW Pharmaceuticals in 2021, adding two cannabidiol  drugs—Epidiolex and Sativex—to its portfolio. As the market for medical cannabis evolves and regulatory clarity improves, Jazz's early entry and growing footprint in this niche will position it as a serious contender for long-term gains.Let’s delve into the company’s strengths and weaknesses to better understand whether the stock deserves a place in your portfolio in 2025.Epidiolex Is on Fire—And So Is Jazz’s Growth Potential. Jazz’s involvement in the cannabis sector centers on Epidiolex—an oral solution approved for treating seizures associated with Lennox-Gastaut syndrome, Dravet syndrome and tuberous sclerosis complex. The drug was originally developed by GW Pharmaceuticals, a pioneer i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/jazz-pharmaceuticals-top-cannabis-investment-114900445.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BN0W2T93.GBP","IE00BN0W2W23.USD","IH","BK4007","CMRX","BK4532","BK4557","BK4547","BK4583","BK4085","LU0109394709.USD","LU0320765992.SGD","BK4113","CBD","BK4510","TLRY","BK4563","BK4139","BK4533","BK4596","IE00BN0W2V16.EUR","LU0889565916.HKD","JAZZ","LU0823416689.USD"],"gpt_icon":1},{"id":"2526495398","title":"Avadel Pharmaceuticals Provides Update at Needham Virtual Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2526495398","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526495398?lang=en_us&edition=fundamental","pubTime":"2025-04-09 01:30","pubTimestamp":1744133400,"startTime":"0","endTime":"0","summary":"DUBLIN, April 08, 2025  -- Avadel Pharmaceuticals plc , a biopharmaceutical company focused on transforming medicines to transform lives, today presented at the 24th Annual Needham Virtual Healthcare Conference.The Company provided an update on patient demand metrics that was in line with guidance from its full-year results announcement on March 3, 2025. It also addressed questions related to the recent developments in United States tariff policy and the potential impact on the biopharmaceutical sector, including Avadel.In Q1 2025 patient demand metrics for LUMRYZ, Avadel’s innovative narcolepsy medication with a market potential of a billion dollars in peak annual sales, all improved versus Q4 2024. These improvements include patient enrollments, patient starts, persistency rates, and net patients on therapy.REVITALYZ, the Company’s Phase 3 pivotal trial studying LUMRYZ in Idiopathic Hypersomnia , is on track to complete enrollment in the second half of 2025.The FDA approval of LUMRYZ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/avadel-pharmaceuticals-provides-needham-virtual-173000248.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4137","HCSG","BK4007","BK4510","BK4563","BK4135","AVDL","IH","BK4085","CNS"],"gpt_icon":0},{"id":"2524473204","title":"Harmony Biosciences Holdings, Inc. (HRMY): A Bull Case Theory","url":"https://stock-news.laohu8.com/highlight/detail?id=2524473204","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524473204?lang=en_us&edition=fundamental","pubTime":"2025-04-04 21:17","pubTimestamp":1743772637,"startTime":"0","endTime":"0","summary":"We came across abullish thesison Harmony Biosciences Holdings, Inc.  on Value Investing Subreddit Page by Long-Access-2143. In this article, we will summarize the bulls’ thesis on HRMY. Harmony Biosciences Holdings, Inc. 's share was trading at $30.97 as of April 3rd. HRMY’s trailing and forward P/E were 12.34 and 8.72 respectively according to Yahoo Finance.Looking ahead, the upside potential is substantial. Management projects WAKIX sales of $820–$860 million in 2025 and over $1 billion by 2027. More significantly, six Phase 3 programs are expected to be in development by the end of 2025, and the company aims to launch a new product every year through 2030. This could drive total sales to over $3 billion by 2028. Of particular note is ZYN-002, targeting Fragile X Syndrome, which has no current treatment but affects over 80,000 patients. Fast-tracked by the FDA, ZYN-002 could launch as early as 2026 and—with full ownership—wou","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/harmony-biosciences-holdings-inc-hrmy-131717960.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0820561818.USD","LU1093756325.SGD","LU1778281490.HKD","LU1989772840.SGD","LU1929549753.HKD","LU1551013425.SGD","LU1674673691.USD","LU0079474960.USD","LU0823434583.USD","LU1035775433.USD","BK4534","LU1914381329.SGD","LU1989772923.USD","LU0354030438.USD","HRMY","LU2756315318.SGD","LU2756315664.SGD","BK4581","LU0823434740.USD","IE00BSNM7G36.USD","LU0689472784.USD","LU1162221912.USD","BK4533","IE00BKVL7J92.USD","LU1551013342.USD","IE00B1XK9C88.USD","LU0942090050.USD","BK4510","LU0820562030.AUD","SG9999001440.SGD","BK4504","LU1496350502.SGD","LU0868494617.USD","LU0354030511.USD","BK4007","BK4567","LU1069344957.HKD","BK4083","BK4563","IH","LU0943347566.SGD","BK4585","LU0823411888.USD","LU0868494708.USD","HD","IE00BZ1G4Q59.USD","LU0234572021.USD","LU0320765646.SGD","BK4550","IE00BWXC8680.SGD"],"gpt_icon":0},{"id":"2524253635","title":"Incannex Healthcare Completes Phase 2 Enrollment in RePOSA Phase 2/3 Trial of IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2524253635","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524253635?lang=en_us&edition=fundamental","pubTime":"2025-04-03 19:30","pubTimestamp":1743679800,"startTime":"0","endTime":"0","summary":"Topline Phase 2 clinical data expected in the first half 2025NEW YORK and MELBOURNE, Australia, April  03, 2025  (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), (Incannex), a clinical-sta","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/03/3055022/0/en/Incannex-Healthcare-Completes-Phase-2-Enrollment-in-RePOSA-Phase-2-3-Trial-of-IHL-42X-an-Oral-Once-Daily-Treatment-for-Obstructive-Sleep-Apnea-OSA.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IH","BK4085","BK4097","BK4218","BK4137","BK4510","AHI","BK4563","BK4167","BK4181","PK","HCSG"],"gpt_icon":0},{"id":"2522041993","title":"Do Its Financials Have Any Role To Play In Driving iHuman Inc.'s (NYSE:IH) Stock Up Recently?","url":"https://stock-news.laohu8.com/highlight/detail?id=2522041993","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522041993?lang=en_us&edition=fundamental","pubTime":"2025-03-27 21:50","pubTimestamp":1743083434,"startTime":"0","endTime":"0","summary":"Most readers would already be aware that iHuman's  stock increased significantly by 28% over the past three months. Given that stock prices are usually aligned with a company's financial performance in the long-term, we decided to study its financial indicators more closely to see if they had a hand to play in the recent price move. Particularly, we will be paying attention to iHuman's  ROE today.Return on Equity or ROE is a test of how effectively a company is growing its value and managing investors’ money. Put another way, it reveals the company's success at turning shareholder investments into profits.Return on equity can be calculated by using the formula:. Return on Equity = Net Profit  ÷ Shareholders' Equity. So, based on the above formula, the ROE for iHuman is:. The 'return' is the yearly profit. So, this means that for every $1 of its shareholder's investments, the company generates a profit of $0.10.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/financials-role-play-driving-ihuman-135034326.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4085","BK4510","IH","BK4563","NYSE"],"gpt_icon":0},{"id":"1140767178","title":"Stock Track | iHuman Stock Plummets 5.79% Following Disappointing Q4 and Full Year 2024 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1140767178","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140767178?lang=en_us&edition=fundamental","pubTime":"2025-03-25 23:59","pubTimestamp":1742918347,"startTime":"0","endTime":"0","summary":"Shares of iHuman Inc. $$ plunged 5.79% in Tuesday's trading session after the Chinese educational technology company reported weaker-than-expected financial results for the fourth quarter and full year of 2024.The Beijing-based firm, which provides tech-powered intellectual development products, saw its revenue decline 7.1% year-over-year to RMB232.7 million  in the fourth quarter. Net income for the quarter fell to RMB26.5 million , compared to RMB33.3 million in the same period last year. The ","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["IH"],"gpt_icon":0},{"id":"1113014243","title":"Stock Track | iHuman Stock Plummets 5.79% as Q4 Revenue and Profit Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=1113014243","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113014243?lang=en_us&edition=fundamental","pubTime":"2025-03-25 23:58","pubTimestamp":1742918333,"startTime":"0","endTime":"0","summary":"Shares of iHuman Inc.  plummeted 5.79% in intraday trading on Tuesday after the company reported declines in revenue and profit for the fourth quarter of 2024. The Chinese provider of tech-powered intellectual development products saw its financial performance impacted by demographic trends and cautious consumer spending.iHuman's fourth-quarter revenue fell 7.1% year-over-year to RMB232.7 million , down from RMB250.4 million in the same period last year. The company attributed this decline to Ch","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Stock Track | iHuman Stock Plummets 5.79% as Q4 Revenue and Profit Decline","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["IH"],"gpt_icon":0},{"id":"2522912360","title":"Ihuman Inc. Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2522912360","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522912360?lang=en_us&edition=fundamental","pubTime":"2025-03-25 16:03","pubTimestamp":1742889837,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nTUA6BQH7G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4510","BK4563","IH","BK4085"],"gpt_icon":0},{"id":"2522904091","title":"Ihuman Q4 Gross Profit RMB 156.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2522904091","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522904091?lang=en_us&edition=fundamental","pubTime":"2025-03-25 16:03","pubTimestamp":1742889837,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nPLX878E6F:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4510","BK4563","BK4085","IH"],"gpt_icon":0},{"id":"2522609170","title":"Press Release: iHuman Inc. Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2522609170","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522609170?lang=en_us&edition=fundamental","pubTime":"2025-03-25 16:03","pubTimestamp":1742889780,"startTime":"0","endTime":"0","summary":"BEIJING, March 25, 2025 /PRNewswire/ -- iHuman Inc.  , a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2024.-- Revenues were RMB232.7 million , compared with RMB250.4. RMB178.2 million in the same period last year.RMB21.9 million in the same period last year.-- Net income was RMB26.5 million , compared with RMB33.3. -- Average total MAUs[1] for the fourth quarter were 25.78 million, compared. At the heart of our success is our long-standing dedication to technological innovation, particularly in artificial intelligence. Since establishing our AI Lab in 2018, we have consistently invested in cutting-edge advancements and seamlessly integrated them into our product offerings. By embracing transformative technologies such as AI-generated content , we became one of the first companies in China to develop and launch a proprietary large language model , a ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","BK4510","BK4085","IH"],"gpt_icon":0},{"id":"2521538747","title":"CNH Industrial says precision technology helping farmers tackle water scarcity","url":"https://stock-news.laohu8.com/highlight/detail?id=2521538747","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521538747?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:45","pubTimestamp":1742816742,"startTime":"0","endTime":"0","summary":"The company said, “Following World Water Day on March 22, CNH brands – Case IH and New Holland – continue to lead the way in breaking new ground in...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cnh-industrial-says-precision-technology-helping-farmers-tackle-water-scarcity?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cnh-industrial-says-precision-technology-helping-farmers-tackle-water-scarcity?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1863844665.USD","LU1201861165.SGD","IH","LU0630314457.HKD","BK4152","LU0477156797.USD","CNH","LU0648000940.SGD","LU1863844749.USD","LU0130103400.USD","BK4085","LU0889565080.SGD","LU0130518102.USD","LU0345781412.USD","LU1803068623.USD","BK4510","LU0345780950.USD","BK4563"],"gpt_icon":0},{"id":"2521745072","title":"Press Release: Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2521745072","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521745072?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:00","pubTimestamp":1742814000,"startTime":"0","endTime":"0","summary":"Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2024. -- Advancing a broad, potential best-in-class orexin receptor 2 . agonist franchise with key data readouts expected in 2025. -- ORX750 Phase 2a CRYSTAL-1 study for the treatment of narcolepsy. type 1 , narcolepsy type 2  and idiopathic hypersomnia.  well underway and on track with data expected across all. three indications in 2025 with first-in-class potential in NT2 and. Dr. Saha concluded, \"In addition to the transformational potential of ORX750 for individuals living with sleep-wake disorders, we see tremendous opportunity with our follow-up OX2R agonists that are being advanced for the treatment of EDS, impaired attention, cognitive deficits and fatigue in neurological, neurodegenerative and neuropsychiatric disorders. ORX142 is prog","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IH","PK","BK4539","NSS","BK4215","MSL","BK4178","BK4588","BK4085","BK4563","BK4022","BK4585","CNTA","BK4510","BK4181","BK4139","BK4218","ESS","BK4232","BK4535","R","BK4597","AAN"],"gpt_icon":0},{"id":"2520199470","title":"HRMY Down 10.8% in Six Months: How Should You Play the Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2520199470","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520199470?lang=en_us&edition=fundamental","pubTime":"2025-03-20 00:14","pubTimestamp":1742400840,"startTime":"0","endTime":"0","summary":"Shares of Harmony Biosciences HRMY have lost 10.8% in the past six months compared with the industry’s decline of 9.7%. The stock has also underperformed the S&P 500 index during this timeframe.The stock was hit last month after the company announced that it received a Refusal to File  letter from the FDA for pitolisant for the treatment of excessive daytime sleepiness  in adult patients with idiopathic hypersomnia .Nonetheless, the fourth-quarter results reported on Feb. 25 were better-than-expected and shares recovered a bit.Let’s dig deeper and understand the company’s strengths and weaknesses in detail to understand how to play the stock in such a scenario.HRMY’s Efforts to Expand Wakix’s Label Suffer Setback. The company was looking to expand the drug’s label for EDS in adult patients with IH. The supplemental new drug application  for pitolisant in IH was submitted in the fourth quarter based on data from the INTUNE study and additional sources.The company targets to initiate a p","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/hrmy-down-10-8-six-161400902.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IH","IE00BN0W2V16.EUR","BK4085","FXS","BK4585","BK4510","BK4533","JAZZ","IE00BN0W2W23.USD","BK4532","LU0109394709.USD","LU0889565916.HKD","BK4007","IE00BN0W2T93.GBP","BK4505","BK4563","AXSM","LU0320765992.SGD","LU0823416689.USD","HRMY"],"gpt_icon":0},{"id":"2518710297","title":"Zevra Reports Full Year 2024 and Fourth Quarter Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2518710297","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518710297?lang=en_us&edition=fundamental","pubTime":"2025-03-12 04:05","pubTimestamp":1741723500,"startTime":"0","endTime":"0","summary":"FY 2024 net revenue of $23.6 million, driven by net revenue of $12.0 million duringfourth quarter of 2024 Entered into asset purchase agreement for sale of PRV for $150 million  Company to host confer","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/11/3040981/16626/en/Zevra-Reports-Full-Year-2024-and-Fourth-Quarter-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4510","BK4563","BK4085","CPS","BSA","BK4124","BK4202","AS","IH"],"gpt_icon":0},{"id":"2518272737","title":"BUZZ-U.S. STOCKS ON THE MOVE-Willis Lease Finance, CME Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2518272737","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518272737?lang=en_us&edition=fundamental","pubTime":"2025-03-11 00:12","pubTimestamp":1741623158,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Willis Lease Finance, CME Group Eikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: h","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nL4N3PT18S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TKO","BK4607","STSS","WSM","REGN","NOW","MNDR","LU0354030511.USD","FBIO","CBRL","DASH","SXTC","ALKT","LU0289739699.SGD","DXCM","BKKT","RKT","ABNB","IH","WLFC","FENC","LU0889565833.HKD","BECN","ENPH","PTGX","LU0048584097.USD","NOVA","CME","W","TRVI","CKPT","MCHP","EXE","SMC","MLYS","BK4599","RDFN","ADM","HUT","PRMB","NEM","TSYW.SI"],"gpt_icon":1},{"id":"2517191113","title":"Centessa Pharmaceuticals Announces Poster Presentation of Phase 1 Clinical Data for ORX750, a novel orexin receptor 2 (OX2R) agonist, at the American Academy of Neurology (AAN) 2025 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2517191113","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517191113?lang=en_us&edition=fundamental","pubTime":"2025-03-07 05:14","pubTimestamp":1741295640,"startTime":"0","endTime":"0","summary":"BOSTON and LONDON, March 06, 2025  -- Centessa Pharmaceuticals plc , a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, today announced that data from the Phase 1 clinical trial of ORX750, an investigational novel highly potent and selective OX2R agonist being progressed for the treatment of narcolepsy type 1 , narcolepsy type 2  and idiopathic hypersomnia , will be presented in a poster sessionat the American Academy of Neurology  2025 Annual Meeting being held April 5-9, 2025, in San Diego, CA. ORX750 is being evaluated in an ongoing Phase 2a clinical trial  in participants with NT1, NT2 and IH.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/centessa-pharmaceuticals-announces-poster-presentation-211400184.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BK4085","BK4563","BK4510","BK4539","CNTA","AFG","IH","AAN","BK4117","BK4178","BK4107","BK4535"],"gpt_icon":1},{"id":"1159599743","title":"Stock Track | iHuman Stock Soars 6.54% as Lumryz Sales Surge and 2025 Guidance Reaffirmed","url":"https://stock-news.laohu8.com/highlight/detail?id=1159599743","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159599743?lang=en_us&edition=fundamental","pubTime":"2025-03-03 22:37","pubTimestamp":1741012673,"startTime":"0","endTime":"0","summary":"Shares of iHuman Inc. , a biopharmaceutical company focused on transforming medicines, skyrocketed 6.54% in pre-market trading on Monday. The surge came after the company reported impressive financial results for the fourth quarter and full year 2024, driven by strong sales of its flagship product Lumryz, and reaffirmed its 2025 guidance.The key highlights that fueled the stock rally include a 158% year-over-year increase in Lumryz sales to $50.4 million in Q4 2024, taking the full-year total to","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Stock Track | iHuman Stock Soars 6.54% as Lumryz Sales Surge and 2025 Guidance Reaffirmed","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["IH"],"gpt_icon":0},{"id":"2516217687","title":"Avadel Pharmaceuticals Reiterates 2025 Guidance as it Reports Fourth Quarter and Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2516217687","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516217687?lang=en_us&edition=fundamental","pubTime":"2025-03-03 20:00","pubTimestamp":1741003200,"startTime":"0","endTime":"0","summary":"-- LUMRYZ generated $50.4 million in sales in the fourth quarter, up 158% year-over-year, taking the full-year total to $169.1 million, in line with preliminary results published January 8 -- Reiterat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/03/3035460/0/en/Avadel-Pharmaceuticals-Reiterates-2025-Guidance-as-it-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNS","BK4085","BK4510","BK4135","BK4563","IH"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":56,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IH\",params:#limit:5,,,undefined,":[{"date":"2025-04-17","symbol":"IH","amount":0.1,"announcedDate":"2025-03-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-17","defaultRemindTime":1744896600000,"name":"洪恩","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-15","payableDate":"2025-04-17","currency":"USD","dateTimestamp":1744862400000,"payDate":"2025-05-15"},{"market":"US","date":"2025-03-25","symbol":"IH","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742875200000,"reportTimeType":"post","actualEps":0.07},{"market":"US","date":"2024-12-26","symbol":"IH","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1735189200000,"reportTimeType":"post","actualEps":0.07},{"market":"US","date":"2024-09-27","symbol":"IH","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1727409600000,"reportTimeType":"pre","actualEps":0.06},{"market":"US","date":"2024-06-28","symbol":"IH","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1719547200000,"reportTimeType":"pre","actualEps":0.06}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IH\",market:\"US\",,,undefined,":[{"executeDate":"2024-03-27","recordDate":"2024-03-28","paymentDate":"2024-05-15","value":0.1,"currency":"USD"},{"executeDate":"2025-04-17","recordDate":"2025-04-17","paymentDate":"2025-05-15","value":0.1,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IH\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IH","date":"2025-04-25","current":7.998984,"percent":0.743728,"low":-133.902359,"twenty":-44.479436,"median":4.416873,"eighty":10.57296,"high":5530.113888,"avg":172.867759,"sd":786.537956,"marketCap":108195029},"quantilePoints":[{"date":"2020-10-09","current":3015.153489,"twenty":2293.787118,"median":2293.827654,"eighty":2726.623155,"marketCap":836391616},{"date":"2020-10-16","current":4671.672124,"twenty":2582.357988,"median":4320.874306,"eighty":4827.609099,"marketCap":1295361515},{"date":"2020-10-23","current":3576.429918,"twenty":3054.346825,"median":3950.507078,"eighty":4590.121793,"marketCap":993215044},{"date":"2020-10-30","current":3382.234713,"twenty":3220.775982,"median":3568.61436,"eighty":4432.812866,"marketCap":938849588},{"date":"2020-11-06","current":4034.939846,"twenty":3394.42959,"median":3740.899882,"eighty":4332.766989,"marketCap":1133310639},{"date":"2020-11-13","current":4488.973537,"twenty":3422.358528,"median":3821.187811,"eighty":4445.304782,"marketCap":1261905850},{"date":"2020-11-20","current":4767.084272,"twenty":3466.034133,"median":3950.507078,"eighty":4477.549968,"marketCap":1348681480},{"date":"2020-11-27","current":5353.033215,"twenty":3519.796499,"median":4037.558213,"eighty":4638.086879,"marketCap":1511255101},{"date":"2020-12-04","current":804.947539,"twenty":3417.540217,"median":4036.249029,"eighty":4748.001842,"marketCap":1214336077},{"date":"2020-12-11","current":790.928981,"twenty":2438.092821,"median":3871.756867,"eighty":4638.086879,"marketCap":1190289818},{"date":"2020-12-18","current":773.47919,"twenty":839.797655,"median":3809.879703,"eighty":4500.791427,"marketCap":1165720814},{"date":"2020-12-24","current":703.755238,"twenty":804.795355,"median":3658.6649,"eighty":4488.973537,"marketCap":1061694607},{"date":"2020-12-31","current":627.687586,"twenty":782.034363,"median":3560.160364,"eighty":4485.036639,"marketCap":947213505},{"date":"2021-01-08","current":693.040329,"twenty":735.871662,"median":3436.813461,"eighty":4471.047521,"marketCap":1054898925},{"date":"2021-01-15","current":631.925226,"twenty":705.894649,"median":3247.685771,"eighty":4422.813267,"marketCap":960804868},{"date":"2021-01-22","current":785.483217,"twenty":699.469274,"median":2654.490571,"eighty":4392.829635,"marketCap":1193949031},{"date":"2021-01-29","current":629.066628,"twenty":676.404566,"median":880.984684,"eighty":4370.542391,"marketCap":963941337},{"date":"2021-02-05","current":656.411833,"twenty":657.588495,"median":826.141001,"eighty":4316.280848,"marketCap":1000010725},{"date":"2021-02-12","current":731.808279,"twenty":655.410123,"median":804.795355,"eighty":4271.81883,"marketCap":1116582807},{"date":"2021-02-19","current":677.913997,"twenty":656.651329,"median":790.928981,"eighty":4262.599202,"marketCap":1034511880},{"date":"2021-02-26","current":635.403102,"twenty":651.117511,"median":778.826173,"eighty":4171.869822,"marketCap":967077806},{"date":"2021-03-05","current":520.076355,"twenty":646.138503,"median":752.847189,"eighty":4036.510866,"marketCap":788821842},{"date":"2021-03-12","current":549.771961,"twenty":636.290266,"median":736.659373,"eighty":4001.166739,"marketCap":832209657},{"date":"2021-03-19","current":530.498446,"twenty":628.593395,"median":733.320641,"eighty":3919.006994,"marketCap":802935951},{"date":"2021-03-26","current":-119.142665,"twenty":622.879828,"median":723.261143,"eighty":3852.888927,"marketCap":682553292},{"date":"2021-04-01","current":-125.368105,"twenty":614.667992,"median":707.536529,"eighty":3823.227334,"marketCap":715614467},{"date":"2021-04-09","current":-113.562337,"twenty":565.399136,"median":703.755238,"eighty":3814.625044,"marketCap":649492117},{"date":"2021-04-16","current":-112.545567,"twenty":523.879982,"median":686.74313,"eighty":3789.756617,"marketCap":646825893},{"date":"2021-04-23","current":-111.847122,"twenty":514.239421,"median":677.913997,"eighty":3708.005889,"marketCap":645226159},{"date":"2021-04-30","current":-117.931495,"twenty":499.145216,"median":663.056135,"eighty":3573.303695,"marketCap":682553292},{"date":"2021-05-07","current":-104.444617,"twenty":-103.746008,"median":657.010573,"eighty":3560.543427,"marketCap":608432271},{"date":"2021-05-14","current":-87.930916,"twenty":-104.32854,"median":653.509616,"eighty":3549.590569,"marketCap":511914969},{"date":"2021-05-21","current":-93.108401,"twenty":-103.746008,"median":650.811921,"eighty":3495.254806,"marketCap":542309920},{"date":"2021-05-28","current":-81.191712,"twenty":-102.442665,"median":647.009022,"eighty":3431.99515,"marketCap":477787304},{"date":"2021-06-04","current":-87.354472,"twenty":-99.120858,"median":643.585878,"eighty":3412.721906,"marketCap":511914969},{"date":"2021-06-11","current":-121.506119,"twenty":-104.444617,"median":637.621013,"eighty":3382.234713,"marketCap":546042634},{"date":"2021-06-18","current":-123.977073,"twenty":-107.5859,"median":632.756179,"eighty":3113.136829,"marketCap":552441571},{"date":"2021-06-25","current":-117.92327,"twenty":-112.451914,"median":628.277906,"eighty":3015.153489,"marketCap":525246088},{"date":"2021-07-02","current":-123.136182,"twenty":-113.47692,"median":626.857752,"eighty":2293.827654,"marketCap":547109123},{"date":"2021-07-09","current":-125.077341,"twenty":-115.016946,"median":620.420958,"eighty":2293.773606,"marketCap":555107795},{"date":"2021-07-16","current":-121.713107,"twenty":-116.058,"median":613.655707,"eighty":1163.539766,"marketCap":540176941},{"date":"2021-07-23","current":-99.159878,"twenty":-116.704465,"median":606.466795,"eighty":850.313746,"marketCap":439926927},{"date":"2021-07-30","current":-81.962671,"twenty":-116.462081,"median":549.771961,"eighty":839.797655,"marketCap":364739415},{"date":"2021-08-06","current":-95.574708,"twenty":-116.394969,"median":526.361906,"eighty":818.374262,"marketCap":423929584},{"date":"2021-08-13","current":-89.247497,"twenty":-116.058,"median":520.076355,"eighty":806.597318,"marketCap":396200856},{"date":"2021-08-20","current":-79.694483,"twenty":-115.969453,"median":511.361225,"eighty":804.825792,"marketCap":352474786},{"date":"2021-08-27","current":-80.770614,"twenty":-115.609201,"median":502.73304,"eighty":795.69142,"marketCap":358873723},{"date":"2021-09-03","current":-79.12817,"twenty":-115.349844,"median":477.975024,"eighty":791.426272,"marketCap":352474786},{"date":"2021-09-10","current":-80.336523,"twenty":-115.089567,"median":-73.530136,"eighty":787.661523,"marketCap":358473789},{"date":"2021-09-17","current":-67.147557,"twenty":-114.328592,"median":-74.614002,"eighty":784.69718,"marketCap":298617065},{"date":"2021-09-24","current":-58.274486,"twenty":-113.704643,"median":-64.467994,"eighty":777.756776,"marketCap":259156953},{"date":"2021-10-01","current":-49.547641,"twenty":-113.511087,"median":-59.474475,"eighty":764.975361,"marketCap":261823177},{"date":"2021-10-08","current":-49.124934,"twenty":-113.402575,"median":-57.951772,"eighty":755.43077,"marketCap":259690198},{"date":"2021-10-15","current":-50.869488,"twenty":-112.875794,"median":-56.415625,"eighty":744.882323,"marketCap":269288603},{"date":"2021-10-22","current":-50.973165,"twenty":-112.5504,"median":-52.468224,"eighty":738.049419,"marketCap":271954827},{"date":"2021-10-29","current":-50.136495,"twenty":-112.489375,"median":-51.782478,"eighty":736.58443,"marketCap":266622380},{"date":"2021-11-05","current":-44.375169,"twenty":-112.089039,"median":-51.143684,"eighty":735.045674,"marketCap":236227428},{"date":"2021-11-12","current":-45.137305,"twenty":-111.53551,"median":-50.869488,"eighty":733.680259,"marketCap":241026631},{"date":"2021-11-19","current":-50.496354,"twenty":-111.004598,"median":-50.832123,"eighty":732.413224,"marketCap":269288603},{"date":"2021-11-26","current":-43.726266,"twenty":-109.507851,"median":-50.628452,"eighty":731.375604,"marketCap":233027960},{"date":"2021-12-03","current":-37.630589,"twenty":-107.079206,"median":-50.257918,"eighty":724.754232,"marketCap":201033274},{"date":"2021-12-10","current":-34.397058,"twenty":-106.044558,"median":-49.787164,"eighty":712.934839,"marketCap":183969442},{"date":"2021-12-17","current":-26.848373,"twenty":-105.424198,"median":-49.547641,"eighty":707.757935,"marketCap":143442840},{"date":"2021-12-23","current":-12.376015,"twenty":-104.978143,"median":-49.124934,"eighty":706.263236,"marketCap":161039917},{"date":"2021-12-31","current":-11.44257,"twenty":-104.32854,"median":-48.296909,"eighty":705.229584,"marketCap":149308532},{"date":"2022-01-07","current":-12.225705,"twenty":-103.746008,"median":-47.398103,"eighty":701.612256,"marketCap":158906938},{"date":"2022-01-14","current":-11.810924,"twenty":-102.450469,"median":-47.2735,"eighty":692.642017,"marketCap":154107735},{"date":"2022-01-21","current":-10.84717,"twenty":-99.159878,"median":-47.015709,"eighty":691.048767,"marketCap":141843106},{"date":"2022-01-28","current":-10.189171,"twenty":-99.120858,"median":-46.619249,"eighty":682.437492,"marketCap":132777945},{"date":"2022-02-04","current":-10.884816,"twenty":-97.125779,"median":-45.583194,"eighty":680.230928,"marketCap":141843106},{"date":"2022-02-11","current":-11.039292,"twenty":-96.220313,"median":-44.375169,"eighty":677.913997,"marketCap":143976085},{"date":"2022-02-18","current":-8.79016,"twenty":-95.574708,"median":-42.210885,"eighty":667.355176,"marketCap":115180868},{"date":"2022-02-25","current":-8.98141,"twenty":-95.510693,"median":-40.959026,"eighty":667.269098,"marketCap":117847091},{"date":"2022-03-04","current":-8.251982,"twenty":-95.20451,"median":-38.926977,"eighty":660.54127,"marketCap":108248686},{"date":"2022-03-11","current":-7.462995,"twenty":-94.808956,"median":-36.013824,"eighty":658.471288,"marketCap":97583791},{"date":"2022-03-18","current":-8.920915,"twenty":-94.676063,"median":-28.19119,"eighty":657.283046,"marketCap":116247357},{"date":"2022-03-25","current":-18.866826,"twenty":-93.419326,"median":-26.998296,"eighty":656.531581,"marketCap":109819592},{"date":"2022-04-01","current":-19.328292,"twenty":-92.356265,"median":-26.514801,"eighty":654.408413,"marketCap":112551689},{"date":"2022-04-08","current":-21.530715,"twenty":-91.682092,"median":-22.02776,"eighty":653.270851,"marketCap":125355047},{"date":"2022-04-14","current":-24.987257,"twenty":-91.447105,"median":-22.037435,"eighty":652.190207,"marketCap":145176144},{"date":"2022-04-22","current":-27.260737,"twenty":-90.097086,"median":-24.216161,"eighty":651.117511,"marketCap":155354545},{"date":"2022-04-29","current":-28.659399,"twenty":-89.238537,"median":-24.921245,"eighty":650.361632,"marketCap":160680849},{"date":"2022-05-06","current":-27.853548,"twenty":-89.112489,"median":-26.439373,"eighty":648.4806,"marketCap":154808791},{"date":"2022-05-13","current":-27.970843,"twenty":-88.563647,"median":-26.73268,"eighty":646.925485,"marketCap":152673498},{"date":"2022-05-20","current":-23.721773,"twenty":-88.058997,"median":-26.616987,"eighty":646.138503,"marketCap":131320561},{"date":"2022-05-27","current":-23.165322,"twenty":-87.724963,"median":-25.883101,"eighty":643.13573,"marketCap":128117620},{"date":"2022-06-03","current":-26.293113,"twenty":-87.494385,"median":-25.157043,"eighty":640.578044,"marketCap":146267617},{"date":"2022-06-10","current":-25.614648,"twenty":-87.306729,"median":-25.614648,"eighty":638.713845,"marketCap":141463206},{"date":"2022-06-17","current":-23.612227,"twenty":-86.817126,"median":-25.605519,"eighty":636.733849,"marketCap":130252914},{"date":"2022-06-24","current":-27.115854,"twenty":-86.136049,"median":-26.077753,"eighty":635.039908,"marketCap":125982327},{"date":"2022-07-01","current":-28.429368,"twenty":-85.885175,"median":-26.439373,"eighty":633.25475,"marketCap":131854384},{"date":"2022-07-08","current":-30.351577,"twenty":-85.747192,"median":-26.616987,"eighty":631.925226,"marketCap":140929382},{"date":"2022-07-15","current":-29.596306,"twenty":-85.614879,"median":-26.666795,"eighty":629.066628,"marketCap":136124972},{"date":"2022-07-22","current":-27.948235,"twenty":-84.864678,"median":-26.848373,"eighty":628.277906,"marketCap":128651444},{"date":"2022-07-29","current":-27.223763,"twenty":-84.560068,"median":-27.09995,"eighty":627.834765,"marketCap":125448503},{"date":"2022-08-05","current":-26.480595,"twenty":-84.530822,"median":-27.115854,"eighty":627.687586,"marketCap":121711739},{"date":"2022-08-12","current":-23.394954,"twenty":-84.184678,"median":-26.846386,"eighty":626.027918,"marketCap":107832330},{"date":"2022-08-19","current":-23.889037,"twenty":-84.005845,"median":-26.6608,"eighty":620.781101,"marketCap":108899977},{"date":"2022-08-26","current":-25.849463,"twenty":-83.715646,"median":-26.586015,"eighty":620.060815,"marketCap":116907328},{"date":"2022-09-02","current":-23.702662,"twenty":-83.660932,"median":-26.480595,"eighty":618.717133,"marketCap":106764684},{"date":"2022-09-09","current":-23.434761,"twenty":-83.338257,"median":-26.293113,"eighty":614.667992,"marketCap":105163213},{"date":"2022-09-16","current":-23.895191,"twenty":-83.187166,"median":-26.002194,"eighty":612.737131,"marketCap":106230860},{"date":"2022-09-23","current":-64.42075,"twenty":-83.126247,"median":-25.981013,"eighty":610.764129,"marketCap":101188968},{"date":"2022-09-30","current":-74.451171,"twenty":-82.37477,"median":-26.212622,"eighty":604.149898,"marketCap":117166174},{"date":"2022-10-07","current":-65.317656,"twenty":-82.044955,"median":-26.480595,"eighty":565.399136,"marketCap":102786689},{"date":"2022-10-14","current":-65.33401,"twenty":-81.971895,"median":-26.586015,"eighty":551.037088,"marketCap":101721542},{"date":"2022-10-21","current":-65.094013,"twenty":-81.820527,"median":-26.6608,"eighty":536.538185,"marketCap":100656395},{"date":"2022-10-28","current":-56.233875,"twenty":-81.757557,"median":-26.846386,"eighty":531.044705,"marketCap":86809483},{"date":"2022-11-04","current":-68.679106,"twenty":-81.439956,"median":-27.115854,"eighty":523.879982,"marketCap":107047277},{"date":"2022-11-11","current":-57.472225,"twenty":-81.334594,"median":-27.190076,"eighty":521.320286,"marketCap":90537498},{"date":"2022-11-18","current":-73.830342,"twenty":-81.266321,"median":-27.322252,"eighty":520.279887,"marketCap":116101027},{"date":"2022-11-25","current":-69.24178,"twenty":-81.21542,"median":-27.372342,"eighty":518.547538,"marketCap":108112424},{"date":"2022-12-02","current":-70.787846,"twenty":-81.038495,"median":-27.470153,"eighty":515.061647,"marketCap":112905586},{"date":"2022-12-09","current":11.251796,"twenty":-80.836909,"median":-27.518685,"eighty":510.950031,"marketCap":107524840},{"date":"2022-12-16","current":12.895086,"twenty":-80.510159,"median":-27.382731,"eighty":506.132555,"marketCap":122961574},{"date":"2022-12-23","current":13.931198,"twenty":-80.01649,"median":-27.322252,"eighty":503.246793,"marketCap":132542996},{"date":"2022-12-30","current":14.359267,"twenty":-79.759674,"median":-27.223763,"eighty":500.939128,"marketCap":138398309},{"date":"2023-01-06","current":21.077172,"twenty":-79.597373,"median":-27.148219,"eighty":494.557622,"marketCap":204935958},{"date":"2023-01-13","current":20.255524,"twenty":-79.192781,"median":-26.966209,"eighty":479.067051,"marketCap":200677548},{"date":"2023-01-20","current":20.474685,"twenty":-79.12817,"median":-26.758595,"eighty":476.154977,"marketCap":200677548},{"date":"2023-01-27","current":20.531717,"twenty":-77.967048,"median":-26.619311,"eighty":21.589051,"marketCap":201209849},{"date":"2023-02-03","current":15.648931,"twenty":-77.398452,"median":-26.534921,"eighty":21.077172,"marketCap":153835043},{"date":"2023-02-10","current":14.716537,"twenty":-76.140032,"median":-26.439373,"eighty":20.611136,"marketCap":143721321},{"date":"2023-02-17","current":15.672184,"twenty":-75.039113,"median":-26.077753,"eighty":20.531717,"marketCap":151705839},{"date":"2023-02-24","current":17.712209,"twenty":-74.699024,"median":-25.970433,"eighty":20.486091,"marketCap":169271778},{"date":"2023-03-03","current":20.018891,"twenty":-74.560532,"median":-25.736073,"eighty":20.419914,"marketCap":192693030},{"date":"2023-03-10","current":18.127093,"twenty":-74.47037,"median":-25.472181,"eighty":20.285663,"marketCap":174062489},{"date":"2023-03-17","current":16.872549,"twenty":-73.954508,"median":-25.301422,"eighty":20.253874,"marketCap":162884164},{"date":"2023-03-24","current":16.222086,"twenty":-72.382996,"median":-24.886301,"eighty":20.065805,"marketCap":157028851},{"date":"2023-03-31","current":10.787756,"twenty":-71.3665,"median":-24.752338,"eighty":20.013517,"marketCap":172465585},{"date":"2023-04-06","current":10.614379,"twenty":-71.119552,"median":-24.651893,"eighty":20.01091,"marketCap":169530932},{"date":"2023-04-14","current":10.897737,"twenty":-70.89832,"median":-24.529866,"eighty":19.995566,"marketCap":174228905},{"date":"2023-04-21","current":10.642547,"twenty":-70.662676,"median":-24.344147,"eighty":19.981604,"marketCap":170062377},{"date":"2023-04-28","current":10.261973,"twenty":-70.26897,"median":-24.087287,"eighty":19.726204,"marketCap":162759014},{"date":"2023-05-05","current":10.375731,"twenty":-69.896663,"median":-23.989384,"eighty":19.345672,"marketCap":164872768},{"date":"2023-05-12","current":10.699055,"twenty":-69.754458,"median":-23.895191,"eighty":19.258934,"marketCap":169100275},{"date":"2023-05-19","current":12.738201,"twenty":-69.647672,"median":-23.817492,"eighty":19.138658,"marketCap":198692823},{"date":"2023-05-26","current":10.145318,"twenty":-69.486863,"median":-23.706814,"eighty":19.049996,"marketCap":157474631},{"date":"2023-06-02","current":8.912544,"twenty":-69.309827,"median":-23.66934,"eighty":18.925288,"marketCap":137922411},{"date":"2023-06-09","current":9.478231,"twenty":-69.195614,"median":-23.578708,"eighty":18.8846,"marketCap":146377425},{"date":"2023-06-16","current":9.95334,"twenty":-68.977174,"median":-23.434761,"eighty":18.784254,"marketCap":153247124},{"date":"2023-06-23","current":7.317993,"twenty":-68.842076,"median":-23.332567,"eighty":18.682471,"marketCap":153247124},{"date":"2023-06-30","current":7.621083,"twenty":-68.7117,"median":-23.313042,"eighty":18.595573,"marketCap":158003069},{"date":"2023-07-07","current":7.569581,"twenty":-68.57814,"median":-23.165322,"eighty":18.516354,"marketCap":156946192},{"date":"2023-07-14","current":7.74125,"twenty":-68.360527,"median":-23.084847,"eighty":18.357204,"marketCap":162759014},{"date":"2023-07-21","current":7.415726,"twenty":-68.154458,"median":-22.784028,"eighty":18.262726,"marketCap":155360877},{"date":"2023-07-28","current":7.58943,"twenty":-67.928832,"median":-22.552521,"eighty":18.177631,"marketCap":159059946},{"date":"2023-08-04","current":8.538508,"twenty":-67.786772,"median":-22.067165,"eighty":18.036212,"marketCap":179140604},{"date":"2023-08-11","current":8.599752,"twenty":-67.392925,"median":-21.761057,"eighty":17.926251,"marketCap":179140604},{"date":"2023-08-18","current":8.200541,"twenty":-67.098258,"median":-21.082907,"eighty":17.784659,"marketCap":169100275},{"date":"2023-08-25","current":7.609195,"twenty":-67.057337,"median":-19.928268,"eighty":17.708857,"marketCap":157210412},{"date":"2023-09-01","current":7.245142,"twenty":-67.046398,"median":-19.328292,"eighty":17.625182,"marketCap":150076494},{"date":"2023-09-08","current":8.165334,"twenty":-66.784088,"median":-18.866826,"eighty":17.482007,"marketCap":167514960},{"date":"2023-09-15","current":7.87776,"twenty":-66.329394,"median":-12.52392,"eighty":17.258673,"marketCap":162759014},{"date":"2023-09-22","current":6.744063,"twenty":-66.219838,"median":-12.376015,"eighty":17.023211,"marketCap":157474631},{"date":"2023-09-29","current":6.570956,"twenty":-66.144779,"median":-12.298084,"eighty":16.797331,"marketCap":153565006},{"date":"2023-10-06","current":6.632418,"twenty":-65.908841,"median":-12.175509,"eighty":16.676727,"marketCap":155005668},{"date":"2023-10-12","current":6.434946,"twenty":-65.651474,"median":-11.881642,"eighty":16.655339,"marketCap":150398718},{"date":"2023-10-20","current":5.972544,"twenty":-65.488282,"median":-11.523642,"eighty":16.591901,"marketCap":139316707},{"date":"2023-10-27","current":5.860553,"twenty":-65.487919,"median":-11.464021,"eighty":16.54281,"marketCap":136678133},{"date":"2023-11-03","current":5.860233,"twenty":-65.478141,"median":-11.354541,"eighty":16.489434,"marketCap":136678133},{"date":"2023-11-10","current":5.965953,"twenty":-65.389152,"median":-11.135132,"eighty":16.41522,"marketCap":139770541},{"date":"2023-11-17","current":6.046997,"twenty":-65.324198,"median":-11.039292,"eighty":16.308917,"marketCap":142482996},{"date":"2023-11-24","current":5.635263,"twenty":-65.228199,"median":-10.915602,"eighty":16.260424,"marketCap":134567274},{"date":"2023-12-01","current":6.069161,"twenty":-64.910178,"median":-10.865993,"eighty":16.236684,"marketCap":145121570},{"date":"2023-12-08","current":5.778828,"twenty":-64.593491,"median":-10.516533,"eighty":16.211144,"marketCap":137997420},{"date":"2023-12-15","current":6.061528,"twenty":-64.487554,"median":-10.314987,"eighty":16.18531,"marketCap":145649284},{"date":"2023-12-22","current":6.073073,"twenty":-64.323712,"median":-10.189171,"eighty":16.139946,"marketCap":145121570},{"date":"2023-12-29","current":5.949859,"twenty":-64.178155,"median":-10.088679,"eighty":16.093099,"marketCap":153301149},{"date":"2024-01-05","current":5.805284,"twenty":-64.099823,"median":-9.94021,"eighty":16.022939,"marketCap":148726216},{"date":"2024-01-12","current":5.514377,"twenty":-63.618717,"median":-9.468635,"eighty":15.900232,"marketCap":141342645},{"date":"2024-01-19","current":6.115656,"twenty":-63.325946,"median":-9.196155,"eighty":15.818308,"marketCap":155582389},{"date":"2024-01-26","current":5.636805,"twenty":-63.196265,"median":-9.088655,"eighty":15.752752,"marketCap":144507032},{"date":"2024-02-02","current":4.964524,"twenty":-62.945888,"median":-8.877979,"eighty":15.703782,"marketCap":126575503},{"date":"2024-02-09","current":4.721345,"twenty":-62.418765,"median":-8.79016,"eighty":15.666016,"marketCap":120774125},{"date":"2024-02-16","current":4.852088,"twenty":-61.561414,"median":-8.645478,"eighty":15.653631,"marketCap":123938513},{"date":"2024-02-23","current":4.714409,"twenty":-61.165479,"median":-8.394602,"eighty":15.648455,"marketCap":119983029},{"date":"2024-03-01","current":4.204659,"twenty":-60.897027,"median":-8.293682,"eighty":15.644092,"marketCap":107061779},{"date":"2024-03-08","current":4.0195,"twenty":-60.462721,"median":-7.902436,"eighty":15.623894,"marketCap":101099140},{"date":"2024-03-15","current":4.08959,"twenty":-59.288225,"median":-7.109283,"eighty":15.559961,"marketCap":102844866},{"date":"2024-03-22","current":3.756903,"twenty":-58.489478,"median":-0.597309,"eighty":15.461807,"marketCap":94406313},{"date":"2024-03-28","current":3.581788,"twenty":-58.274486,"median":3.785359,"eighty":15.429213,"marketCap":89659626},{"date":"2024-04-05","current":3.754028,"twenty":-58.103317,"median":3.754028,"eighty":15.265664,"marketCap":93878903},{"date":"2024-04-12","current":3.93018,"twenty":-57.800228,"median":3.753613,"eighty":15.153111,"marketCap":98240580},{"date":"2024-04-19","current":3.619091,"twenty":-57.472225,"median":3.754028,"eighty":14.825454,"marketCap":90450741},{"date":"2024-04-26","current":3.696217,"twenty":-56.803966,"median":3.745618,"eighty":14.749615,"marketCap":92296674},{"date":"2024-05-03","current":3.672048,"twenty":-56.415625,"median":3.710255,"eighty":14.716537,"marketCap":91769265},{"date":"2024-05-10","current":3.572862,"twenty":-56.233875,"median":3.704611,"eighty":14.545739,"marketCap":89516801},{"date":"2024-05-17","current":3.992595,"twenty":-54.288637,"median":3.72302,"eighty":14.504524,"marketCap":100048189},{"date":"2024-05-24","current":4.215887,"twenty":-53.28149,"median":3.745854,"eighty":14.359267,"marketCap":105313884},{"date":"2024-05-31","current":4.173666,"twenty":-53.217826,"median":3.753613,"eighty":14.206804,"marketCap":104260745},{"date":"2024-06-07","current":4.228116,"twenty":-52.954726,"median":3.756363,"eighty":13.978696,"marketCap":105577168},{"date":"2024-06-14","current":4.263687,"twenty":-52.66213,"median":3.77762,"eighty":13.734399,"marketCap":106367022},{"date":"2024-06-21","current":3.909764,"twenty":-52.476232,"median":3.813814,"eighty":13.427207,"marketCap":97415342},{"date":"2024-06-28","current":3.956328,"twenty":-52.444201,"median":3.815294,"eighty":13.251214,"marketCap":98468481},{"date":"2024-07-05","current":4.428231,"twenty":-52.374063,"median":3.843672,"eighty":13.075932,"marketCap":91096509},{"date":"2024-07-12","current":4.292969,"twenty":-52.159314,"median":3.862231,"eighty":12.944148,"marketCap":88463662},{"date":"2024-07-15","current":4.188792,"twenty":-52.099759,"median":3.872037,"eighty":12.919617,"marketCap":86357384},{"date":"2024-08-02","current":4.079809,"twenty":-52.040203,"median":3.876302,"eighty":12.895086,"marketCap":84251107},{"date":"2024-08-09","current":4.016242,"twenty":-51.782478,"median":3.880567,"eighty":12.738201,"marketCap":83724537},{"date":"2024-08-16","current":3.990932,"twenty":-51.641514,"median":3.892399,"eighty":12.704329,"marketCap":83197968},{"date":"2024-08-23","current":4.075087,"twenty":-51.157034,"median":3.894801,"eighty":12.522599,"marketCap":85304246},{"date":"2024-08-30","current":3.898504,"twenty":-51.130333,"median":3.903824,"eighty":12.321334,"marketCap":82144829},{"date":"2024-09-06","current":3.870408,"twenty":-51.121558,"median":3.906794,"eighty":11.93542,"marketCap":81618260},{"date":"2024-09-13","current":3.859099,"twenty":-51.002405,"median":3.903824,"eighty":11.456534,"marketCap":81091690},{"date":"2024-09-20","current":3.9671,"twenty":-50.890223,"median":3.9082,"eighty":11.273623,"marketCap":83950962},{"date":"2024-09-27","current":4.319659,"twenty":-50.809704,"median":3.909764,"eighty":11.108562,"marketCap":92149648},{"date":"2024-10-04","current":5.879801,"twenty":-50.767392,"median":3.931399,"eighty":11.029879,"marketCap":110501873},{"date":"2024-10-11","current":5.499863,"twenty":-50.549193,"median":3.939908,"eighty":10.979463,"marketCap":102646289},{"date":"2024-10-18","current":5.214344,"twenty":-50.442871,"median":3.958702,"eighty":10.954849,"marketCap":96754602},{"date":"2024-10-25","current":5.219422,"twenty":-50.292234,"median":3.966788,"eighty":10.944012,"marketCap":96885528},{"date":"2024-10-31","current":5.105491,"twenty":-50.185064,"median":3.968042,"eighty":10.942007,"marketCap":94790706},{"date":"2024-11-08","current":5.167096,"twenty":-50.081411,"median":3.991764,"eighty":10.930004,"marketCap":95529131},{"date":"2024-11-15","current":4.672759,"twenty":-49.897475,"median":4.008147,"eighty":10.907481,"marketCap":85364006},{"date":"2024-11-22","current":4.440508,"twenty":-49.78473,"median":4.0271,"eighty":10.878829,"marketCap":81069620},{"date":"2024-11-29","current":4.736699,"twenty":-49.6958,"median":4.040143,"eighty":10.857926,"marketCap":86411417},{"date":"2024-12-06","current":4.689102,"twenty":-49.565261,"median":4.04993,"eighty":10.843894,"marketCap":85364006},{"date":"2024-12-13","current":4.838269,"twenty":-49.5214,"median":4.067482,"eighty":10.830193,"marketCap":87982534},{"date":"2024-12-20","current":5.089027,"twenty":-49.339197,"median":4.079809,"eighty":10.809498,"marketCap":92172178},{"date":"2024-12-27","current":6.383451,"twenty":-49.076179,"median":4.096351,"eighty":10.803058,"marketCap":92172178},{"date":"2025-01-03","current":6.149372,"twenty":-48.881161,"median":4.109295,"eighty":10.799568,"marketCap":88776402},{"date":"2025-01-10","current":6.013414,"twenty":-48.785915,"median":4.112845,"eighty":10.790662,"marketCap":86426438},{"date":"2025-01-17","current":6.249589,"twenty":-48.017792,"median":4.116582,"eighty":10.787892,"marketCap":89820830},{"date":"2025-01-24","current":5.959023,"twenty":-47.641921,"median":4.161776,"eighty":10.760214,"marketCap":86165331},{"date":"2025-01-31","current":6.018765,"twenty":-47.445019,"median":4.173666,"eighty":10.730465,"marketCap":87470866},{"date":"2025-02-07","current":6.284576,"twenty":-47.356742,"median":4.176545,"eighty":10.708582,"marketCap":90865258},{"date":"2025-02-14","current":6.707059,"twenty":-47.326502,"median":4.204659,"eighty":10.66515,"marketCap":96912498},{"date":"2025-02-21","current":6.723628,"twenty":-47.283745,"median":4.218352,"eighty":10.63128,"marketCap":97654042},{"date":"2025-02-28","current":7.467655,"twenty":-47.216733,"median":4.228962,"eighty":10.608026,"marketCap":108098324},{"date":"2025-03-07","current":7.685188,"twenty":-47.054251,"median":4.238658,"eighty":10.595139,"marketCap":111753823},{"date":"2025-03-14","current":9.29828,"twenty":-46.801402,"median":4.25916,"eighty":10.589398,"marketCap":135253459},{"date":"2025-03-21","current":9.805225,"twenty":-46.709104,"median":4.263687,"eighty":10.608026,"marketCap":142564457},{"date":"2025-03-28","current":9.162264,"twenty":-46.618583,"median":4.29309,"eighty":10.595139,"marketCap":124320249},{"date":"2025-04-04","current":8.29809,"twenty":-46.382185,"median":4.29859,"eighty":10.589398,"marketCap":112356376},{"date":"2025-04-11","current":7.023312,"twenty":-45.672372,"median":4.324447,"eighty":10.583231,"marketCap":94670650},{"date":"2025-04-17","current":7.471132,"twenty":-45.010945,"median":4.368261,"eighty":10.575507,"marketCap":100912671},{"date":"2025-04-25","current":7.998984,"twenty":-44.479436,"median":4.416873,"eighty":10.57296,"marketCap":108195029}],"updateTime":1745733332188}}}